scispace - formally typeset
C

Carrie Lin

Researcher at Boston Children's Hospital

Publications -  4
Citations -  553

Carrie Lin is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Enhancer & Transcription factor. The author has an hindex of 3, co-authored 3 publications receiving 471 citations. Previous affiliations of Carrie Lin include Harvard University.

Papers
More filters
Journal ArticleDOI

An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level

TL;DR: It is found that common genetic variation at BCL11A associated with fetal hemoglobin (HbF) level lies in noncoding sequences decorated by an erythroid enhancer chromatin signature, illustrating how GWASs may expose functional variants of modest impact within causal elements essential for appropriate gene expression.
Journal ArticleDOI

HbF-Associated Genetic Variation Marks an Erythroid Regulatory Element Essential for BCL11A Transcription and Subsequent Stage-Specific Globin Expression

TL;DR: HbF-associated genetic variation in BCL 11A modulates the function of a critical erythroid enhancer of BCL11A, and consequently expression of B CL11A itself is regulated, demonstrating the importance of quantitative level expression in the regulation of the stage-specific globin genes.
Posted ContentDOI

Plasmodium falciparum exploits CD44 as a co-receptor for erythrocyte invasion

TL;DR: In this article , the authors found that CD44 can be efficiently deleted from primary human hematopoietic stem cells using CRISPR/Cas9 genome editing, and that the efficiency of ex-vivo erythropoiesis to enucleated cultured red blood cells (cRBCs) is not impacted by lack of CD44.